β Galactosidase is a lysosomal β Galactosidase that hydrolyzes the terminal β Galactose from Ganglioside and Keratan sulfate. In lysosome, the mature β Galactosidase protein associates with Cathepsin A and Neuraminidase 1 to form the lysosomal multienzyme complex . An alternative splicing at the RNA level of β Galactosidase results a catalytically inactive β Galactosidase that plays an important role in vascular development. Defects of β-galactosidase (GLB1) are the cause of diseases like GM1-gangliosidosis which is a lysosomal storage disease and Morquio Syndrome B that cause patients to have abnormal elastic fibers. More than 100 mutations have been identified for β Galactosidase, which result in different residual activities of the mutant enzymes and a spectrum of symptoms in the two related diseases.
Product Name:
Beta-Galactosidase/GLB1 Recombinant Protein (RPES3548)
Recombinant Human beta-Galactosidase is produced by our Mammalian expression system and the target gene encoding Leu24-Val677 is expressed with a 6His tag at the C-terminus.
Purity:
> 95 % as determined by reducing SDS-PAGE.
Mol Mass:
74.6 kDa
AP Mol Mass:
90 kDa
Formulation:
Supplied as a 0.2 µm filtered solution of 20mM TrisHCl, 150mM NaCl, pH 8.0.
Shipping:
This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs.Upon receipt, store it immediately at<-20°C.
Stability and Storage:
Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles.
![Anti-GLB1/Beta-galactosidase [R07-9Z6] Monoclonal Antibody (AGMB03265)](https://cdn11.bigcommerce.com/s-h68l9z2lnx/images/stencil/590x590/products/274554/679288/anti-glb1beta-galactosidase-r07-9z6-monoclonal-antibody-agmb03265__22390.1773038430.jpg?c=2 "Anti-GLB1/Beta-galactosidase [R07-9Z6] Monoclonal Antibody (AGMB03265)")